The largest community of pharma leaders

Prolucent Health Appoints Kathy Douglas as SVP of Clinical Services/Chief Nursing Officer, and Derek Quackenbush as Chief Financial Officer

DALLAS–()–Prolucent Health®, provider of next-generation healthcare workforce innovations that align labor needs with data-driven decision making, welcomes the addition of Kathy Douglas as SVP clinical services and chief nursing officer, and Derek Quackenbush as CFO to its new management team. Douglas and Quackenbush significantly bolster Prolucent’s market opportunity as a leading workforce management partner for healthcare providers.

Douglas and Quackenbush previously teamed with CEO Bruce Springer at BidShift/Concerro in similar roles. “I have had the privilege of working with Kathy and Derek and know first hand that their success with emerging healthcare technology companies coupled with their in-depth experience in workforce management is a strong asset to Prolucent as we pursue our company growth initiatives,” said Springer, co-founder and CEO of Prolucent Health. “We’re excited to have them both on board as we work to develop more cohesive, data-driven, end-to-end solutions for workforce management in healthcare.”

Douglas is a nationally recognized nurse leader, entrepreneur, author, and filmmaker. She has served on the executive team of several health tech start-up companies including Oceania, BidShift/Concerro, API Healthcare, and Ability Network. She led the initiative to define excellence and evidence in healthcare staffing, has published extensively on workforce topics, and was recognized as “Leader to Honor” by Nurse Leader magazine. Douglas is a registered nurse and holds a master’s degree in health administration from University of San Francisco and is a graduate of the Stanford University Business School Executive Program.

Quackenbush is a recognized business leader who has served on the executive team of several healthcare companies including Sleep Data, Vericare, Healthy Circles, and Concerro. His background spans C-suite roles with private, public, and international companies ranging from start-up to Fortune 500 and Big-4 public accounting firms. Quackenbush has participated in $300M in M&A, joint venture, and investment transactions in organizations ranging from $2-200M in revenue. Quackenbush is a member of the board, treasurer, and Finance Committee chair of Sharp Healthcare and a member of the board and treasurer of the San Diego Seniors Foundation. He received a BS degree in political science from the University of California, Berkeley.

About Prolucent Health, Inc.

Prolucent empowers modern workforce management, streamlining the way healthcare meets total workforce needs with end-to-end solutions that provide cost-effective and sustainable answers to healthcare’s workforce challenges. For additional information, please visit



Recent Articles

City of Hope Distinguished Scientist Debbie Thurmond Named New Director of Diabetes & Metabolism Research Institute

DUARTE, Calif.--(BUSINESS WIRE)-- #CityofHope--Debbie C. Thurmond, Ph.D., has been named the...

Did You Know That One in Eight Women Are at Risk for Breast Cancer?

LEHI, Utah & SAN FRANCISCO--(BUSINESS WIRE)--Breast cancer affects one in eight...

Global Companion Diagnostic Market to Surpass US$ 12,114.6 Million by 2027, Says Coherent Market Insights (CMI)

SEATTLE--(BUSINESS WIRE)-- #CompanionDiagnostic--According to Coherent Market Insights, the global companion diagnostic...
2020 Call for Writers

Are you looking to inspire others in the pharma industry through your writing? You’re invited to submit your articles to become a Featured Writer for The Pharmaceutical Marketing Group website.